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Abstract
Background—Transplanting autologous patient-derived enteric neuronal stem/progenitor cells 
(ENSCs) is an innovative approach to replacing missing enteric neurons in patients with 
Hirschsprung disease (HSCR). Using autologous cells eliminates immunologic and ethical 
concerns raised by other cell sources. However, whether postnatal aganglionic bowel is permissive 
for transplanted ENSCs and whether ENSCs from HSCR patients can be successfully isolated, 
cultured, and transplanted in vivo remains unknown.
Methods—ENSCs isolated from the ganglionic intestine of Ednrb−/− mice (HSCR-ENSCs) were 
characterized immunohistochemically and evaluated for their capacity to proliferate and 
differentiate in vitro. Fluorescently-labeled ENSCs were co-cultured ex vivo with aganglionic 
Ednrb−/− colon. For in vivo transplantation, HSCR-ENSCs were labeled with lentivirus expressing 
GFP and implanted into aganglionic embryonic chick gut in ovo and postnatal aganglionic 
Ednrb−/− rectum in vivo.
Key Results—HSCR-ENSCs maintain normal capacity self-renewal and neuronal 
differentiation. Moreover, the Ednrb−/− aganglionic environment is permissive to engraftment by 
wild-type ENSCs ex vivo and supports migratrion and neuroglial differentiation of these cells 
following transplantation in vivo. Lentiviral-GFP-labeled HSCR-ENSCs populated embryonic 
chick hindgut and postnatal colon of Ednrb−/− HSCR, with cells populating the intermuscular 
layer and forming enteric neurons and glia.
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Conclusions & Inferences—ENSCs can be isolated and cultured from mice with HSCR, and 
transplanted into the aganglionic bowel of HSCR littermates to generate enteric neuronal 
networks. These results in an isogenic model establish the potential of using autologous-derived 
stem cells to treat HSCR and other intestinal neuropathies.
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Introduction
The enteric nervous system (ENS) is an extensive network of neurons and glial cells within 
the wall of the gastrointestinal tract critically important in regulating gut motility and other 
fundamental aspects of gut function1. As a result, enteric neuropathies, in which enteric 
neurons are abnormal or congenitally absent, can cause significant morbidity. Hirschsprung 
disease (HSCR) is characterized by absent ganglion cells in the distal bowel due to failure of 
neural crest-derived precursors to colonize the entire gut. The aganglionic region produces a 
functional obstruction, and current treatment requires surgical resection of this segment. 
While surgery is life-saving, over 50% of children have persistent problems, including 
severe constipation, fecal incontinence, and enterocolitis2,3. Cell-based therapy offers the 
potential to introduce new neurons into the aganglionic region as a novel therapy for this 
disease4–6.
Neuronal stem cells can be isolated from postnatal rodent and human intestine and are able 
to migrate and differentiate when transplanted into the embryonic gut7–11. More recently, it 
has been shown that enteric neuronal stem/progenitor cells (ENSCs) derived from neonatal 
rodent and human can be expanded in culture and transplanted into postnatal colon of mice 
in vivo, resulting in cell engraftment, migration and neuroglial differentiation12–14. These 
studies show that ENSC transplantation is achievable in postnatal recipient gut and offers 
the potential to replace missing neurons with neuronal stem cells for the treatment of enteric 
neuropathies. However, little research has been done to determine whether the postnatal 
aganglionic environment of HSCR is permissive to transplanted neuronal stem cells.
Several groups have demonstrated the isolation, expansion, and differentiation of ENSCs 
from the intestine of rodents and humans with HSCR9,11,14,15, raising the possibility of 
establishing patient-derived ENSCs as donor cells for cell therapy. The use of patient-
derived autologous ENSCs would have significant advantages over other cell sources by 
eliminating the risk of immunological rejection and minimizing ethical concerns16. 
However, whether ENSCs derived from HSCR patients have a similar capacity to form 
extensive neuroglial networks as cells derived from healthy individuals is unknown. Since 
nearly all patients with HSCR carry mutations that affect enteric neural crest-derived cells17, 
patient-derived ENSCs may not be able to generate adequate enteric neurons and glial cells 
following transplantation18.
In order to address these questions, we used Endothelin receptor type B (Ednrb)-null mice, 
which possess distal colorectal aganglionosis, as a model of HSCR in the current study. Our 
goal was to test whether the postnatal aganglionic colon is permissive for ENSCs and to 
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determine whether ENSCs isolated from Ednrb−/− mice could serve as a source of cells for 
isogenic transplantation into the aganglionic segment of recipient mice. Our results establish 
the feasibility of this approach and support the potential of autologous cell transplantation 
for neurointestinal diseases.
Materials and methods
Animals
Experiments were approved by the Massachusetts General Hospital Institutional Animal 
Care and Use Committee. Ednrbtm1Ywa mice on a hybrid C57BL/6J-129Sv background were 
purchased from Jackson Laboratory (JAX#003295). Homozygous pups (Ednrb−/−) were 
identified by white coat color and exhibit distal aganglionosis19. Genotyping was performed 
using a polymerase chain reaction-based assay to distinguish wild type (Ednrb+/+) from 
heterozygous (Ednrb+/−) littermates20. We also used Actb-DsRed mice (strain Tg(CAG-
DsRed*MST)1Nagy/J; Jackson Labs Stock #005441), in which all cells express red 
fluorescent protein21. Fertilized White Leghorn chicken (Gallus gallus) eggs were obtained 
from commercial breeders and maintained at 37°C in a humidified incubator. Embryos were 
staged by the number of embryonic days (E).
Tissue preparation and immunohistochemistry
Cells and tissues were fixed in 4% paraformaldehyde. For whole-mount preparations of 
mouse longitudinal muscle-myenteric plexus (LMMP), distal colon was opened along the 
mesenteric border, pinned on Sylgard-coated plates, and fixed. The mucosa and submucosa 
were removed. For cryosection, tissues were transferred to 15% sucrose overnight at 4°C. 
The medium was changed to 7.5% gelatin containing 15% sucrose at 37°C for 1 hour and 
rapidly frozen at −50°C in methylbutane (Sigma). Frozen sections were cut at 12 μm 
thickness.
Immunohistochemistry was performed as previously described 22. Cells or tissues were 
fixed, washed, and permeablized with 0.1% Triton X-100 for 30 minutes. Primary 
antibodies included mouse anti-Tuj1 (1:100, Covance, Dedham, MA), mouse anti-HuC/D 
(1:100, Life Technologies, Carlsbad, CA) mouse anti-CN (kind gift from Dr. Tanaka 23), 
rabbit anti-S-100 (1:100, NeoMarkers, Fremont, CA), rabbit anti-p75 (1:500, Promega, 
Madison, WI), rabbit anti-αSMA (1:100, Abcam, Cambridge, MA, USA), rabbit anti-nNOS 
(1:500, Santa Cruz Biotechnology), rabbit anti-calretinin (1:200, Life Technologies), rabbit 
anti-Nestin (1:200, Abcam), rabbit anti-synaptophysin (ab14692, 1:200, Abcam), goat anti-
GFAP (1:500, Abcam), goat anti-ChAT (1:50, Millipore, Billerica, MA), goat anti-Ret (1:20 
R&D Systems, Minneapolis, MN), goat anti-GFP (1:400, Rockland, Limerick, PA), and 
human antineuronal nuclear type 1 (Hu; 1:16,000 kind gift from Dr. Lennon). Secondary 
antibodies included goat anti-mouse IgG Alexa Fluor 546, goat anti-rabbit Alexa Fluor 488, 
donkey anti-goat Alexa Fluor 488, donkey anti-goat Alexa Fluor 546, donkey anti-mouse 
Alexa Fluor 546, and donkey anti-mouse Alexa Fluor 488 (Life Technologies; Carlsbad, 
CA). Cell nuclei were stained with DAPI (Vector Labs, Burlingame, CA). Images were 
captured with a Nikon 80i microscope or with a Nikon A1R laser-scanning confocal 
microscope
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Enteric neuronal stem/progenitor cell (ENSC) cultures
DsRed mice were sacrificed on postnatal day 14–21 (P14–21) and the gastrointestinal tract 
from duodenum to anus removed. Small intestine of P10–14 Ednrb−/− mice or Ednrb+/+ 
littermates were also used to obtain HSCR-ENSCs or non-HSCR-ENSCs. The LMMP was 
separated and dissociated with dispase (250 μg ml−1; StemCell Technologies, Vancouver, 
Canada) and collagenase XI (1 mg ml−1; Sigma Aldrich, St. Louis, MO) at 37°C for 1 hour 
with gentle pipetting. The cell suspension was passed through a 40 μm cell strainer and 
cultured at a density of 50,000 cells ml−1 in proliferation medium, consisting of Neurocult 
NSC Basal Medium (StemCell Technologies) supplemented with 20 ng ml−1 epidermal 
growth factor (EGF; StemCell Technologies) and 10 ng ml−1 basic fibroblast growth factor 
(bFGF; StemCell Technologies), 0.0002% Heparin (StemCell Technologies) and 100 U 
ml−1 Penicillin-Streptomycin (Life Technologies) for 7–10 days to form enteric 
neurospheres. Neurospheres were passaged every 7–10 days with gentle Accutase (StemCell 
Technologies) dissociation at 37°C for 20–30 minutes followed by re-plating.
To induce differentiation, neurospheres were dissociated with Accutase (StemCell 
Technologies) at 37°C for 30 minutes with gentle pipetting. The cell suspension was passed 
though a 40 μm cell strainer and plated at 50,000 cells ml−1 on glass-bottom chamber slides 
coated with 20 μg ml−1 fibronectin (Biomedical Technologies, Ward Hill, MA). Cells were 
cultured for 7 days in NeuroCult NSC Differentiation Medium (StemCell Technologies) and 
then processed for immunohistochemistry.
Differentiation assay
Neurospheres isolated from Ednrb−/− or Ednrb+/+ littermates were dissociated with Accutase 
and replated as above. Following 7 days in differentiation conditions, cells were fixed and 
processed for immunohistochemistry. Following staining with the neuronal marker, Tuj1, 
random images were taken from each culture condition and neuronal density measured 
quantitatively using ImageJ software.
Proliferation assay
10 nM 5-ethynyl-2′-deoxyuridine (EdU) was added to the culture medium 24 hours prior to 
fixation. Neurospheres were dissociated with Accutase and centrifuged (800 g for 2 minutes; 
Shandon Cytospin 3) onto a poly-L-lysine slide. Neural crest cells were visualized using p75 
immunoreactivity, with EdU incorporation detected using the ClickiT EdU Imaging Kit 
(Invitrogen). Ten random images were taken from each group and the number of p75+EdU− 
or p75+EdU+ cells counted using ImageJ software.
Preparation and transduction of lentiviral vector
The lentiviral plasmid (pLenti-GIII-CMV-GFP-2A-Puro) was purchased from Applied 
Biological Materials Inc and amplified using plasmid DNA Maxiprep Kit (Life 
Technologies) according to the manufacturer’s protocol. Lentiviral vector stocks were 
produced by co-transfection of 293T cells with the transfer vector, packaging plasmid and a 
plasmid coding for the VSV-G envelope glycoprotein24. The viral titer was determined by 
qPCR using a probe against the WPRE element; stocks were stored at −80°C until use.
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Enteric neurospheres from Ednrb−/− or Ednrb+/+ mice were gently triturated to single cell 
suspensions using Accutase at 750 cells μl−1 and plated in proliferation medium. Following 
2 hours at 37°C, lentivirus was added at multiplicity of infection (MOI) in the range of 3–6. 
After 48 hours, successful transduction was confirmed by green fluorescent protein (GFP) 
expression.
To determine transduction efficiency, enteric neurospheres were generated from lentiviral-
transduced ENSCs and then dissociated and plated on fibronectin-coated cover slips. 
Presence of GFP fluorescence was quantitatively measured using ImageJ software to 
evaluate lentiviral transduction efficiency.
Co-culture of LMMP and neurospheres
LMMP was obtained from mouse colon and a 5×5 mm segment suspended as a catenary 
culture using a piece of filter paper with a rectangular-shaped window. DsRed expressing 
neurospheres were placed onto the LMMP and covered with 10 μL Matrigel (BD 
biosciences, CA, USA) to secure the neurospheres in position. Co-cultures were maintained 
for 4 or 7 days in medium containing 10% fetal bovine serum (Life Technologies) and 100 
U ml−1 Penicillin-Streptomycin (Life Technologies), and then fixed overnight in 4% 
paraformaldehyde.
Measurement of ENSC migration on LMMP
Tile scans of wholemount preparations were taken with a Nikon AZ100 fluorescent 
microscope. Migration distance was measured by dividing the image into octants (Supp. Fig. 
1) and measuring the distance from the edge of the neurosphere to the distalmost DsRed+ 
cell in each octant. The average distance was calculated to represent the migration distance 
in each preparation.
Neurosphere transplantation to aganglionic chick hindgut
Chick aganglionic hindgut was dissected from E5 chicken embryos. Three GFP+ 
neurospheres were implanted into the proximal hindgut mesenchyme using fine forceps 
under microscopic visualization. The recombinants were transplanted onto the 
chorioallantoic membrane (CAM) of an E10 chick host for 7 days as described 
previously22,25.
In vivo transplantation of neurospheres to Ednrb−/− mice
Recipient 2-week-old Ednrb−/− or Ednrb+/+ mice were anesthetized by isoflurane (Henry 
Schein Animal Health, Dublin, OH) inhalation. A circum-anal skin incision was made and 
the distal rectum exposed. One or 2 DsRed+ or GFP+ neurospheres, labeled with 0.1% 
methylene blue, were transplanted into a pocket created between the two muscle layers of 
the rectal wall. The pocket was closed with 8–0 nylon suture. At 1–2 weeks following 
surgery, recipient mice were sacrificed and the rectum removed.
In vivo proliferation studies
Intraperitoneal injection with 50 mg kg−1 EdU was performed 1 and 2 days following 
transplantation. The distal colon was removed, processed as above, and EdU incorporation 
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detected using the ClickiT EdU Imaging Kit (Invitrogen) according to the manufacturer’s 
instructions.
Quantitative PCR
Total mRNA was extracted from proliferating neurospheres using the RNeasy Mini kit 
(Qiagen, Santa Clarita, CA, USA) and cDNA synthesized with the Superscript III Reverse 
Transcription Kit (Invitrogen). Ednrb expression levels were measured using quantitative 
PCR (qPCR) with Gapdh as the internal standard. The primers used were: EdnrB forward, 
GAACTCCACGCTGCTAAGAATCATCTAC and EdnrB reverse, 
CAGCTTACACATCTCAGCTCCAAATGG. Relative expression was calculated by 2−ΔCt.
Statistical analyses
Data were expressed as means ± SD. Paired t-tests were used to evaluate the statistical 
significance between two groups. When more than two groups were compared, means were 
statistically compared by one-way ANOVA with Tukey’s post hoc multiple-comparison 
tests of differences. Statistical significance was considered at p<0.05.
Results
DsRed+ enteric neurospheres engraft onto aganglionic colon ex vivo
Based on our previous isolation and propagation of postnatal mouse ENSCs12,22,26, we 
generated DsRed-expressing enteric neurospheres to allow cell tracking following 
transplantation. The gastrointestinal tract was removed from two-week-old Actb-DsRed 
mice. Following mechanical and enzymatic dissociation, cells were cultured in medium 
containing EGF and bFGF for 7–10 days to form DsRed+ enteric neurospheres (Fig. 1A). 
When cultured on fibronectin-coated cover slips in medium devoid of EGF and bFGF, 
DsRed+ neurospheres differentiate into enteric neurons and glia expressing Tuj1 (Fig. 1B) 
and GFAP (Fig. 1C), respectively.
Previous reports suggest that aneural gut, including embryonic gut of HSCR mice9, is more 
permissive for enteric neural crest cells than neural gut27,28. To test this in postnatal 
intestine, we co-cultured DsRed+ enteric neurospheres with LMMP colon explants isolated 
from postnatal day 7 (P7) Ednrb−/− mice or Ednrb+/+ littermates. Immunostaining with Tuj1 
shows extensive neuronal differentiation of cells migrating from the neurospheres (Fig. 1E). 
After 4 and 7 days of co-culturing, the extent of cell migration and fiber extension were 
quantitatively compared between neural and aneural environments (Fig. 1D,F) as described 
in Suppl. Fig. 1. Immunohistochemical analysis revealed that most of the DsRed-expressing 
cells migrate on the surface of the LMMP, with no difference in the location of the cells in 
the two different environments (data not shown). ENSCs migrate significantly further in an 
aganglionic environment compared to ganglionic recipient gut both at 4 days (394.3 ± 6.9 
μm vs 107.7 ± 16.1 μm, Fig 1F) and 7 days (670.7 ± 71.3 μm vs 227.7 ± 26.9 μm, Fig. 1F). 
In normal ganglionic intestine, there was no significant difference in the migration distance 
between 4 and 7 days. In contrast, in aganglionic gut, there was a significant increase in 
migration distance between day 4 and day 7 (Fig. 1F).
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Aganglionic HSCR colon is permissive to transplanted ENSCs in vivo
Based on our ex vivo experiments, we tested if DsRed+ ENSCs are able to engraft, migrate, 
and differentiate in the aganglionic colon of HSCR mice in vivo. Two-week-old Ednrb−/− 
mice were anesthetized and the aganglionic distal colon exposed through a perianal skin 
incision. DsRed+ enteric neurospheres were microsurgically implanted into a pocket created 
in the muscular wall of the colon (Fig. 2A). At 1–2 weeks following surgery, recipient mice 
were sacrificed and the distal colon removed. Of the 8 Ednrb−/− mice that underwent 
transplantation, DsRed+ cells were found in 7 recipients (5 at 1 week and 2 at 2 weeks 
following surgery). Wholemount preparation from recipient Ednrb−/− mice 2 weeks 
following surgery showed the presence of surviving transplanted ENSCs in the host gut, 
confirming their successful engraftment (Fig. 2B), along with projections of DsRed+ fibers 
emanating from the neurospheres (Fig. 2C, arrowheads). S-100 immunostaining 
demonstrates the presence of endogenous glial cells in the myenteric plexus of the proximal, 
ganglionated colon (Fig. 2D, arrowheads). An isolated glial fiber with no associated cell 
body can be seen in the aganglionic region, possibly representing an extrinsic fiber (Fig. 
2D). Transplanted DsRed+ cells are located in the inter-myenteric layer of the aganglionic 
region (Fig. 2D,E; arrows), with fibers extending distally (Fig. 2E, arrowheads). The precise 
distance of longitudinal cell migration was difficult to determine in these preparations. 
DsRed+ ENSCs differentiate into neurons (Fig. 2F) and glia (Fig. 2G), suggesting that the 
aganglionic colon can support the survival, migration, and differentiation of transplanted 
ENSCs in vivo.
ENSCs can be isolated from ganglionic intestine of HSCR mice
While the successful isolation of ENSCs from postnatal intestine and their transplantation 
into aganglionic colon of HSCR mice represents an important step forward, clinical 
application of cell therapy will require autologous ENSCs transplantation. To determine if 
ENSCs can be isolated from mice with HSCR, we dissected the LMMP layer from the 
ganglionic small intestine of 1–2 week-old Ednrb−/− mice and formed neurospheres as 
described above (Fig. 3A–D). Immunohistochemistical characterization of sectioned 
neurospheres reveals the presence of neural crest-derived cells (Fig. 3A, p75), enteric neural 
crest cells (Fig. 3B, Ret), neurons (Fig. 3C, Tuj1), and glial cells (Fig. 3D, GFAP). The 
proportion of p75+ neural crest cells in HSCR-derived neurospheres was 46.9 ± 8.0 %, 
which is equivalent to that seen in control (non-HSCR) neurospheres (55.9 ± 13.8 %, n=3 in 
each group, p=NS). Upon differentiation, HSCR-derived ENSCs give rise to Tuj1+ neurons 
and S-100+ glial cells (Fig. 3E), as well as neuronal subtypes, including choline 
acetyltransferase (Fig. 3F, ChAT), neuronal nitric oxide synthase (Fig. 3G, nNOS), and 
calretinin (Fig. 3H).
Ednrb−/− ENSCs retain proliferation and neuronal differentiation potential
Although autologous stem cells have a number of advantages in regenerative medicine, the 
use of ENSCs from a patient with HSCR may be theoretically problematic18. We therefore 
tested whether HSCR-ENSCs from Ednrb−/− mice have an altered capacity for self-renewal 
or neuronal differentiation. Expression of Ednrb transcript in ENSCs isolated from Ednrb−/− 
mice and Ednrb+/+ littermates was quantified by qPCR, confirming a lack of Ednrb 
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expression in HSCR-ENSCs (Fig. 3I). To examine their capacity for self-renewal, EdU was 
added to the culture medium while growing neurospheres and the proportion of proliferating 
neural crest cells was quantified immunohistochemically. Despite the loss of Ednrb 
expression in HSCR-ENSCs, no significant alteration was seen in the percentage of dividing 
neural crest cells within neurospheres from HSCR mice compared to those from non-HSCR 
mice (10.5 ± 5.5 % vs 8.8 ± 3.3 %, Fig. 3J). Dissociated neurospheres were also plated on 
fibronectin-coated cover slips to determine their ability of undergo neuronal differentiation, 
as determined by Tuj1 immunoreactivity. Enteric neuronal density was equivalent between 
ENSCs derived from Ednrb−/− and Ednrb+/+ intestine (0.24 ± 0.07 mm2 vs 0.28 ± 0.07 mm2, 
Fig. 3K). These data suggest that the loss of Ednrb expression in HSCR-ENSCs does not 
alter their ability to proliferate or differentiate and supports their use for cell replacement 
therapy.
Lentiviral infection achieves long-term labeling of HSCR-ENSCs
In order to trace HSCR-ENSCs following transplantation, we generated a lentiviral vector 
expressing GFP, and transduced this construct into dissociated neurospheres. GFP 
fluorescence at 48 hours confirms a high efficiency of transduction, with 64.1 ± 3.8% of 
cells infected (Suppl. Fig 2A, Table 1). Lentivirus-mediated gene delivery results in stable 
and long-term transgene expression, even after neuronal or glial differentiation (Suppl. Fig. 
2B, C). Immunohistochemical characterization of lenti-GFP-transduced cells demonstrated 
that 27.3 ± 2.1% and 35.9 ± 0.1% of GFP+ cells are neurons and glia, respectively (Suppl. 
Fig. 2B, C, and Table 1). Conversely, 53.2 ± 0.8% of Tuj1+ cells are labeled by GFP and 
52.2 ± 5.9% of glial cells are GFP+.
We also transduced ENSCs isolated from Ednrb+/+ littermates and found the overall 
transduction efficiency (61.6 ± 6.3%) and the proportion of neurons in the GFP+ transduced 
cells (27.4 ± 6.6%) to be similar to that seen with mutant ENSC. Interestingly, the loss of 
Ednrb expression was associated with a higher percentage of glial differentiation (43.2 ± 
0.9%) as compared to Ednrb+/+ ENSCs (27.6 ± 1.7%). Similarly, the proportion of GFP+ 
cells that underwent glial differentiation was greater in the HSCR-ENSC (35.9 ± 0.1% vs 
24.3 ± 0.4%), suggesting that Ednrb−/−-derived ENSCs preferentially differentiate into glia 
(Table 1).
HSCR-ENSCs survive, migrate, and differentiate in aganglionic chick gut
To determine the capacity of HSCR-ENSC to survive and generate neurons within the 
aneural gut environment, we implanted GFP+ HSCR-ENSC into the aganglionic hindgut of 
an embryonic day 5 (E5) chick (n=9), a stage at which enteric neural crest cells have not yet 
colonized the hindgut. Following neurosphere transplantation (Fig. 4A), hindguts were 
cultured on the CAM of an E10 host chick embryo for 7 days. GFP+ cells migrated all the 
way down the length of the chick embryonic gut, representing a distance of approximately 
450 μm (Fig. 4B). Neuronal differentiation is shown by co-expression with Tuj1 (Fig. 4D) 
and Hu (Fig. 4E). The absence of staining with CN antibody, a chick-specific neuronal 
antibody23, confirms that these are not endogenous chick-derived enteric neurons (Fig. 4C). 
Co-expression of GFP and GFAP confirms the presence of glial differentiation (Fig. 4F). 
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These findings demonstrate that HSCR-ENSCs survive, migrate, and differentiate in the 
embryonic aganglionic environment.
HSCR-derived ENSCs engraft in the postnatal aganglionic colon of HSCR mice in vivo
To test whether autologous HSCR-derived ENSCs can be transplanted into postnatal mouse 
colon in vivo, GFP+ HSCR-ENSCs were microsurgically implanted into the distal colorectal 
wall of 2 week-old Ednrb−/− or Ednrb+/+ mice (n=9 Ednrb−/− and n=4 Ednrb+/+; Fig. 2A). 
All recipient mice survived the procedure and GFP+ cells were found in 11 of 13 recipients 
(4 of 5 recipients at 1 week and 7 of 8 recipients at 2 weeks following transplantation). GFP
+ HSCR-ENSCs were present in the aganglionic colon with cells seen differentiating into 
neurons (Fig. 5A, arrows). A proportion of Tuj1+ cells are noted to be GFP-negative (Fig. 
5A), likely representing neuronal differentiation of transplanted cells that lack lenti-GFP 
transduction, since the transduction efficiency is only about 60% (Table 1). Anti-αSMA 
staining of recipient colon shows HSCR-ENSCs in the submucosal area with few fibers 
projecting toward the muscular layer (Fig. 5B). Longitudinal cell migration was consistently 
observed and at 2 weeks following transplantation, HSCR-ENSCs migrated up to 940 μm in 
HSCR (Ednrb−/−) mice. In comparison, HSCR-ENSCs migrated up to 1000 μm in non-
HSCR (Ednrb+/+) mice. With regard to differentiation of transplanted cells, co-localization 
of αSMA and GFP was infrequently seen in the aganglionic recipient colon (Fig. 5B,C).
To determine if transplanted cells proliferate and differentiate into neurons following 
transplantation, EdU was injected into recipient mice intraperitoneally following 
transplantation. Incorporation of EdU is observed in GFP+ HSCR-ENSCs-derived neurons 
(Fig. 5D–G, closed arrows), suggesting transplanted HSCR-ENSCs are able to proliferate 
and give rise to neurons in vivo. Tuj1-expressing neurons that co-express GFP, but do not 
incorporate EdU, are also seen (Fig. 5D–G, open arrows), representing either neurons that 
were already present within the neurosphere prior to transplantation or cells that 
differentiated following the EdU pulse. GFP+ HSCR-ENSCs also give rise to glial cells 
(Fig. 5H and H′) and enteric neuronal subtypes, including nNOS- (Fig. 5I and I′) and 
calretinin-expressing neurons (CalR; Fig. 5J). Finally, synaptophysin-immunoreactive 
vesicles are seen on GFP+ HSCR-ENSC-derived cells (SYP; Fig. 5K, arrows) in recipient 
aganglionic colon 1 week after transplant, suggesting synaptic formation. More abundant 
and robust synaptophysin-positive vesicles are seen in the recipient colon of wild-type 
Ednrb+/+ mice 2 weeks following surgery (Fig. 5L and M).
Discussion
In the current study, we demonstrate that ENSCs can be isolated from the ganglionated 
intestine of mice with HSCR and have the capacity to generate neurons and glia both ex vivo 
and following transplantation into the aganglionic colon in vivo. These findings add to 
important previous work in this field and support the potential application of autologous 
cell-based therapy for treating enteric neuropathies.
ENSCs have been successfully isolated from embryonic8–10,12,15 and 
postnatal12,13,15,22,29–31 rodent gut and postnatal human intestine8,10,11,14,32,33. Identifying 
the optimal source of ENSCs for cell therapy applications is an important goal. We chose to 
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derive enteric neurospheres from unsorted cells dissociated from the gut wall. The cells in 
these spheres are heterogeneous, including both neural crest- and non-neural crest-derived 
cells34. We consistently find that approximately half of the cells within the neurosphere are 
neural crest-derived, and the absence of Ednrb expression did not alter this proportion. We 
find that our neurospheres gave rise to glia, neurons, and multiple neuronal subtypes in vivo, 
with proliferative potential, and little smooth muscle differentiation. It has been suggested 
that non-neural crest cells in the neurosphere may produce paracrine factors to support the 
neural crest cells, although this remains unknown34. Our observations support such a 
“bystander” effect and suggest that spontaneous (non-selected) neurospheres can be a 
therapeutic source for the treatment of enteric neuropathies.
To date, most studies have characterized ENSCs following transplantation into the 
preganglionated embryonic chick or mouse hindgut, i.e. prior to the arrival of migrating 
enteric neural crest-derived cells. The embryonic aganglionic colon of Ret- or Ednrb-
deficient mice has also been successfully transplanted with enteric neuronal progenitors in 
co-culture experiments7,9,28,35. Transplantation into postnatal intestine in vivo, either normal 
or aganglionic, has been infrequently reported12–14. This represents a potentially significant 
hurdle as the postnatal gut microenvironment may not be sufficiently permissive to allow 
extensive colonization by enteric neural crest-derived cells, possibly due to the presence of a 
hostile extracellular matrix in the mature gut28,36 or to the inhibitory effect of pre-existing 
neurons27,28. We found that transplanted cells are able to engraft in the postnatal ganglionic 
and aganglionic bowel. Interestingly, the extent of cell migration and neurofiber projection 
was significantly greater in the aganglionic environment in our ex vivo experiment. In ex 
vivo LMMP experiments, migration occurs almost exclusively on the surface of the LMMP 
rather than within the myenteric plexus, but this is due to the fact that cells are placed on top 
of the muscle surface ex vivo, rather than implanted into the gut wall as we do for in vivo 
transplantation. Surface migration on the LMMP is unlikely to contribute to functional 
integration of ENSCs. We use the LMMP explants to test the permissiveness of the 
environment and not as an indicator of how ENSCs will respond in vivo since the explanted 
LMMP offers a very different and artificial environment. Interestingly, our results suggest 
that the normal intestine may represent a less favorable milieu for ENSC migration, but the 
mechanisms underlying this are unknown. While transplanted cells were able to engraft 
effectively in the aganglionic colon in vivo, the area of engraftment and extent of neuronal 
differentiation were limited. Modifications of the transplanted cells or the recipient 
environment may be needed in order to enhance the success of ENSC transplantation.
The use of autologous ENSCs would be significantly advantageous for cell replacement 
therapy in order to minimize the risk of immune rejection, ethical concerns surrounding 
embryonic stem cells, and potential problems with clinical use of induced pluripotent stem 
cells16,37. The capacity of HSCR-derived ENSCs to proliferate, migrate, and differentiate 
following transplantation has not been previously explored. We found that ENSCs isolated 
from HSCR mice have an equivalent capacity for cell proliferation and neuronal 
differentiation in comparison to those isolated from wild-type littermates. This is consistent 
with previous work by Kruger et al35, who demonstrated that ENSCs derived from Ednrb-
deficient rats showed no alteration in their multipotency and proliferation. Furthermore, we 
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show that HSCR-ENSCs were able to replace missing enteric neurons and expressed 
synaptophysin-immunoreactive vesicles in the distal HSCR colon in vivo, suggesting 
functional connectivity. This is the first demonstration of successful engraftment and 
replacement of enteric neurons in HSCR colon using isogenic ENSCs. Anitha et al38 
injected an enteric neuronal cell line into the colon of Endrb−/− mice via laparotomy, with 
successful engraftment and differentiation into neurons and glial cells. However, this enteric 
neuronal cell line has a different genetic background from the Ednrb−/− recipient mice, 
raising the problem of immunological rejection, which plagues human solid organ and bone 
marrow allogeneic transplantation39. Successful isolation and culturing of ENSCs from 
postnatal Ednrb−/− mice enabled us to examine their in vivo behavior following 
transplantation into Ednrb-null mice from the same colony. Demonstrating the survival, 
proliferation, and appropriate differentiation of Ednrb−/− neuronal progenitors, and their 
transplantation into littermates, are important first steps toward achieving autologous cell 
transplantation.
Endothelin-3 (Et3) is produced by the mesenchyme of the developing gut40–42 and acts 
through its transmembrane receptor, Ednrb, which is expressed by enteric neural crest 
cells41,43. Et3 has been proposed to enhance the proliferation of enteric neural crest 
cells40,41 and to prevent the premature neuronal differentiation of multilineage progenitors, 
thereby maintaining enough progenitors to colonize the entire bowel44–46. Interestingly, we 
find that postnatal ENSCs can be cultured and expanded in the absence of Ednrb signaling 
and, furthermore, that these postnatal ENSCs can give rise to equivalent number of neurons 
despite the lack of Edrnb expression. These observations suggest that Ednrb is not required 
for postnatal ENSCs to proliferate and differentiate normally. During mouse embryogenesis, 
Ednrb signaling is temporally required specifically between E10 and E12.547,48, and its role 
postnatally is largely unknown. As inhibition of Et3 signaling failed to block colonization of 
the mouse hindgut by neural crest cells when applied after E1348, it is clear that the role of 
Ednrb signaling is different in the early embryonic gut versus the late embryonic or 
postnatal gut, an area that merits further research.
We consistently observed that Ednrb-null ENSCs give rise to more glial cells in culture than 
wild-type ENSCs did. Although Kruger et al35 demonstrated that Ednrb deficiency did not 
alter the potency of multilineage differentiation of embryonic gut NCSCs, including glial 
differentiation, a more recent study showed that Et3 decreased glial proliferation presumably 
by downregulating Sox10 expression, resulting in decreased glial cell numbers in cultured 
p75+ rat enteric neural crest cells49. Additionally, increased numbers and early appearance 
of S-100-expressing glial cells have been observed in developing peripheral nerves of 
Ednrb-null rats50. Our results are consistent with these observations and implicate a possible 
role for Ednrb signaling in balancing neuronal and glial cell numbers in the postnatal ENS.
A limitation of this study is that the recipient Ednrb−/− mice do not live longer than 4–5 
weeks due to bowel obstruction and enterocolitis51. We previously showed that functioning 
enteric neurons can be generated from ENSCs 3–5 weeks following transplantation into 
wild-type mice in vivo12. Since it is not feasible to follow our recipient Ednrb−/− mice for 
this long after transplantation, functional analysis of recipient animals could not be 
performed. Although Anitha et al38 showed improved colon motor function just one week 
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after transplantation of an enteric neuronal cell line into Ednrb−/− mice, further studies using 
other mouse models with longer survival, such as ENS injury caused by benzalkonium 
chloride (BAC)14, are needed to demonstrate functional improvement following ENSC 
transplantation using HSCR-derived cells.
Lentiviral transduction proved to be a useful method to label ENSCs fluorescently in order 
to permit their long-term tracking. Previous studies have used retrovirus or adenovirus 
vectors to label enteric or CNS-derived neural stem cells transplanted into the gut15,52,53. 
However, the use of lentivirus has advantages over those previous approaches by infecting 
both dividing and non-dividing cells, providing long-term, stable transgene expression, and 
generating low immunogenicity34,54,55. Moreover, we achieved a higher transduction 
efficiency (>60%) than previously reported52. While GFP expression is retained after cell 
differentiation in vivo, a few GFP−/Tuj1+ cells were seen in the transplant site, showing the 
limitations associated with not achieving 100% cell labeling in our system. Nonetheless, 
gene delivery using lentiviral vectors may allow for genetic engineering of neuronal stem 
cells prior to transplantation in order to achieve expression of desired transgenes, such as 
sustained release of neurotrophic factors52,53,56, or to optimize the host microenvironment. 
Similarly, lentiviral gene delivery could also be exploited to correct the genetic mutation 
present in patient-derived stem cells, such as RET or EDNRB mutations frequently found in 
human HSCR57–59.
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Key Messages
• ENSCs can be isolated from wild-type (DsRed mouse) and HSCR (Ednrb−/−) 
mice with no significant difference in their capacity for cell proliferation and 
neuronal differentiation.
• Ex vivo co-cultures of wild-type ENSCs and aganglionic colon demonstrate that 
the aganglionic microenivronment is permissive for ENSC migration and 
proliferation.
• Wild-type ENSCs survive, migrate, and differentiate into neurons and glial cells 
following transplantation into the aganglionic colon of HSCR mice in vivo.
• HSCR-ENSCs can be transplanted in vivo into the aganglionic colon of mice 
with HSCR colon, where they are able to proliferate, migrate, and undergo 
neuroglial differentiation.
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Figure 1. Isolation and transplantation of ENSCs into Ednrb−/− aganglionic colon ex vivo
Enteric neurospheres derived from Actb-DsRed mouse colon express red fluorescent protein 
(A). Enteric neuronal stem/progenitor cells (ENSCs) within those neurospheres differentiate 
into neurons (Tuj1, B) and glial cells (GFAP, C) that retain DsRed expression. DsRed+ 
enteric neurospheres co-cultured with LMMP isolated from an aganglionic colon of 
Ednrb−/− mice exhibit significant cell migration and fiber projection at 7 days (D), with 
extensive neuronal differentiation (E). ENSC migration is significantly better in aganglionic 
LMMP as compared to control (F) *: p < 0.05, ***: p < 0.001. Scale bars: 100 μm (A), 50 
μm (B and C), 500 μm (D), and 200 μm (E).
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Figure 2. In vivo transplantation of ENSCs into aganglionic colon of Ednrb−/− mice
Methylene blue-labeled DsRed+ enteric neurospheres were microsurgically implanted into 
the rectal wall of Ednrb−/− mice via a trans-anal incision (A), and the colon fixed 1–2 weeks 
later. Wholemount immunostaining shows successful ENSCs engraftment (B) with 
migration of transplanted cells and prominent fiber projections (C, arrowheads). Recipient 
Ednrb−/− distal colon was sectioned longitudinally and examined immunohistochemically. 
Endogenous S100+ glial cells (D, arrowheads) are seen proximal to the transplanted DsRed
+ ENSCs (D, arrows), which are present in the inter-myenteric layer of the aganglionic 
region (E, arrows), with fibers extending distally (E, arrowheads). An isolated DsRed-
nergative glial fiber, possibly extrinsically derived, is seen in the aganglionic region (D). 
Transplanted ENSCs differentiate into neurons (F) and glia (G). Scale bars: 1cm (B), 500 
μm (C), 500 μm (D and E), and 50 μm (F and G).
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Figure 3. Isolation, characterization, proliferation and differentiation of ENSCs derived from 
Ednrb−/− mice
Immunofluorescent staining was performed on enteric neurospheres generated from 
dissociated small intestinal LMMP of Ednrb−/− mice (A–D). HSCR gut-derived ENSCs 
(HSCR-ENSCs) contain neural crest (A, p75; B, ret), neuronal (C, Tuj1), and glial (D, 
GFAP) cells. HSCR-ENSCs exhibit neuroglial differentiation following dissociation (E). A 
subset of neurons exhibits immunoreactivity to choline acetyltransferase (F, ChAT), nitric 
oxide synthase (G, NOS), or calretinin (H). qRT-PCR shows decreased Ednrb expression in 
HSCR-ENSCs (I), but no significant change in the rate of p75+ neural crest cell proliferation 
(J) or neuronal differentiation (K) compared to ENSCs from wild-type littermates. *p < 
0.05. Scale bars: 100 μm (A–E), 50 μm (F–H).
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Figure 4. In ovo transplantation of ENSCs into embryonic aganglionic chicken hindgut
Aganglionic hindgut was removed from embryonic day 5 (E5) and GFP+ HSCR-ENSCs 
were transplanted into the cecal region (A, arrows). This transplanted tissue was grafted onto 
an E10 CAM. After 7 days, transplanted GFP+ HSCR-ENSCs migrate within the gut wall 
(B), project fibers (D) and differentiate into Tuj1+ (D) and Hu+ (E) neurons, and GFAP+ 
glial cells (F). GFP expressing cells show no CN staining (chick-specific neuron marker) in 
the gut (C), confirming they are not host-derived. Scale bars: 250 μm (A), 150 μm (B, C, D, 
and F), and 60 μm (E). ep, epithelium; hg, hindgut.
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Figure 5. In vivo transplantation of Ednrb−/− ENSCs into aganglionic colon of Ednrb−/− mice
Lentiviral GFP-expressing HSCR-ENSCs were transplanted into aganglionic distal colon of 
Ednrb−/− mice and the colon fixed 1–2 weeks later. Transplanted cells engraft within the gut 
(A, arrows), mainly in the submucosal layer (B), and differentiate into Tuj1+ neurons (A, 
arrows), rarely giving rise to αSMA-expressing smooth muscle cells (B and C, CM; circular 
muscle). The presence of Tuj1+/GFP− cells likely represents neuronal differentiation of 
transplanted cells that lack lenti-GFP transduction. Neuronal proliferation following 
transplantation is demonstrated by incorporation of EdU and colocalization with Tuj1 and 
GFP (D–G, arrows). Non-dividing neurons are GFP+Tuj1+Edu− cells (D–G, open arrows). 
Transplanted ENSCs differentiate into glia (H and H′, arrows), nNOS-expressing neurons (I 
and I′, arrows), and calretinin (CalR) positive neurons (J, arrows). Synaptophysin (SYP) 
expressing vesicles are identified on transplanted ENSCs-derived cells in aganglionic colon 
at 1 week following surgery (K, arrows). Synaptophysin expression is seen more 
prominently in ganglionic recipient colon at 2 weeks following surgery (L and M, arrows) 
where the endogenous myenteric plexus also labels with synaptophysin (L, arrowheads). 
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Panels A–J were captured with confocal microscopy. Scale bars: 200 μm (A), 100 μm (B 
and C), 20 μm (D–J), 10 μm (K and M), and 100 μm (L).
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Table 1
Characterization of lentiviral GFP (Lv-GFP) transduced cells
Ednrb−/− ENSCs Ednrb+/+ ENSCs
Lv-GFP transduction efficiency (%) 64.1 ± 3.8 61.6 ± 6.3
GFP+Tuj+/GFP+ (%) 27.3 ± 2.1 27.4 ± 6.6
GFP+S-100+/GFP+ (%) 35.9 ± 0.1 ** 24.3 ± 0.4
GFP+Tuj+/Tuj (%) 53.2 ± 0.8 * 41.0 ± 4.0
GFP+S-100+/S-100+ (%) 52.2 ± 5.9 59.0 ± 5.5
Tuj+/DAPI (%) 33.6 ±2.7 37.3 ±4.2
S-100+/DAPI (%) 43.2 ±0.9 *** 27.6 ±1.7
*
P<0.05,
**p<0.01,
***p<0.001
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